Aterian (NASDAQ:ATER) Issues Earnings Results

Aterian (NASDAQ:ATER) posted its quarterly earnings data on Friday. The company reported ($0.39) EPS for the quarter, topping the consensus estimate of ($0.69) by $0.30, Zacks reports. The firm had revenue of $18.00 million during the quarter, compared to analyst estimates of $15.82 million. Aterian had a negative return on equity of 68.00% and a negative net margin of 27.52%.

Aterian Trading Down 5.2%

Shares of NASDAQ:ATER opened at $1.09 on Friday. Aterian has a 12 month low of $0.52 and a 12 month high of $2.10. The company has a 50-day moving average price of $0.75 and a 200 day moving average price of $0.74. The company has a market cap of $11.79 million, a price-to-earnings ratio of -0.42 and a beta of 0.66.

Institutional Trading of Aterian

Several institutional investors have recently added to or reduced their stakes in the company. Susquehanna International Group LLP lifted its stake in Aterian by 310.2% in the third quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares during the last quarter. Citadel Advisors LLC increased its position in shares of Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares during the period. XTX Topco Ltd purchased a new position in Aterian during the second quarter valued at approximately $55,000. Finally, Goldman Sachs Group Inc. increased its holdings in Aterian by 73.0% during the first quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after buying an additional 9,026 shares during the period. Institutional investors own 7.02% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a research note on Monday, April 20th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Aterian currently has a consensus rating of “Sell”.

Aterian Company Profile

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.